Chemotherapy
Chemotherapy . | Dose density per week . | Cumulative dose . | |||||
---|---|---|---|---|---|---|---|
ABVE-PC . | ABVD2 . | Escalated BEACOPP8 . | ABVE-PC (3 cycles) . | ABVE-PC (5 cycles) . | ABVD20 . | Escalated BEACOPP8 . | |
Doxorubicin, mg/m2 | 20 | 12.5 | 11.7 | 180 | 300 | 300-400 | 280 |
Bleomycin, units/m2 | 5 | 5 | 3.3 | 45 | 75 | 120-150 | 80 |
Vincristine, mg/m2 | 0.93 | 0 | 0.46 | 8.4 | 14 | 0 | 16 |
Etoposide, mg/m2 | 125 | 0 | 200 | 1125 | 1875 | 0 | 4800 |
Cyclophosphamide, mg/m2 | 267 | 0 | 417 | 2400 | 4000 | 0 | 10 000 |
Prednisone, mg/m2 | 133 | 0 | 187 | 1200 | 2000 | 0 | 4480 |
Procarbazine, mg/m2 | 0 | 0 | 233 | 0 | 0 | 0 | 5600 |
Vinblastine, mg/m2 | 0 | 3 | 0 | 0 | 0 | 72-96 | 0 |
DTIC, mg/m2 | 0 | 188 | 0 | 0 | 0 | 4500-6000 | 0 |
Chemotherapy . | Dose density per week . | Cumulative dose . | |||||
---|---|---|---|---|---|---|---|
ABVE-PC . | ABVD2 . | Escalated BEACOPP8 . | ABVE-PC (3 cycles) . | ABVE-PC (5 cycles) . | ABVD20 . | Escalated BEACOPP8 . | |
Doxorubicin, mg/m2 | 20 | 12.5 | 11.7 | 180 | 300 | 300-400 | 280 |
Bleomycin, units/m2 | 5 | 5 | 3.3 | 45 | 75 | 120-150 | 80 |
Vincristine, mg/m2 | 0.93 | 0 | 0.46 | 8.4 | 14 | 0 | 16 |
Etoposide, mg/m2 | 125 | 0 | 200 | 1125 | 1875 | 0 | 4800 |
Cyclophosphamide, mg/m2 | 267 | 0 | 417 | 2400 | 4000 | 0 | 10 000 |
Prednisone, mg/m2 | 133 | 0 | 187 | 1200 | 2000 | 0 | 4480 |
Procarbazine, mg/m2 | 0 | 0 | 233 | 0 | 0 | 0 | 5600 |
Vinblastine, mg/m2 | 0 | 3 | 0 | 0 | 0 | 72-96 | 0 |
DTIC, mg/m2 | 0 | 188 | 0 | 0 | 0 | 4500-6000 | 0 |
DTIC indicates dacarbazine.